SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-21-011133
Filing Date
2021-05-06
Accepted
2021-05-06 16:03:33
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vxrt20210331_10q.htm   iXBRL 10-Q 1020673
2 EXHIBIT 31.1 ex_235704.htm EX-31.1 16905
3 EXHIBIT 32.1 ex_235705.htm EX-32.1 9683
9 pipelineqone.jpg GRAPHIC 378797
  Complete submission text file 0001437749-21-011133.txt   6202318

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20210331.xsd EX-101.SCH 59915
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vxrt-20210331_cal.xml EX-101.CAL 43986
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20210331_def.xml EX-101.DEF 391547
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20210331_lab.xml EX-101.LAB 337619
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20210331_pre.xml EX-101.PRE 417696
10 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20210331_10q_htm.xml XML 786861
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35285 | Film No.: 21897624
SIC: 2836 Biological Products, (No Diagnostic Substances)